LawP.K.Myoblast transfer therapy.Lancet341: 247; 1993.
8.
LawP.; GoodwinT.; FangQ.; DuggiralaV.; LarkinC.; FlorendoA.; KirbyD.; DeeringM.; LiH.; ChenM.; YooT.; CornettJ.; LiL.; ShirzadA.; HolcombR.Experimental treatment of Duchenne muscular dystrophy (DMD) with myoblast transfer therapy (MTT).Cell Transplantation1: 229; 1992.
9.
LawP.K.; GoodwinT.G.; FangQ.; DuggiralaV.; LarkinC.; FlorendoJ.A.; KirbyD.S.; DeeringM.B.; LiH.J.; ChenM.; YooT.J.; CornettJ.; LiL.M.; ShirzadA.; QuinleyT.; HolcombR.L.Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys.Cell Transplantation1: 235244; 1992.
10.
LawP.; LiH.; ChenM.; AjamoughliG.; FangQ.; GoodwinT.Pioneering animal experimentation of myoblast transfer therapy.Cell Transplantation1: 201; 1992.
11.
PartridgeT.A.; MorganJ.E.; CoultonG.R.; HoffmanE.P.; KurkelL.M.Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts.Nature337: 176179; 1989.